Logo

Cancer Genetics Inks Agreement with Harvard Pilgrim for Access to Cancer Dx Services

Jul 16, 2015 | staff reporter

NEW YORK (GenomeWeb) – Cancer Genetics today announced that it has signed an agreement with Harvard Pilgrim Healthcare to provide its cancer diagnostic services.

Harvard Pilgrim's provider network includes more than 135 hospitals and 28,000 doctors covering more than one million people in Massachusetts, Connecticut, and Maine. Cancer Genetics provides molecular testing services for hematological, urogenital, and HPV-associated cancers.

In April, Rutherford, New Jersey-based Cancer Genetics signed an agreement with America's Choice Provider Network to provide access to its cancer diagnostic tests.

Filed under

Cancer
Business News
Molecular Diagnostics
Cancer Genetics
Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.